These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 25986596

  • 1. Transcutaneous Peptide Immunotherapy of Japanese Cedar Pollinosis Using Solid-in-Oil Nanodispersion Technology.
    Kitaoka M, Shin Y, Kamiya N, Kawabe Y, Kamihira M, Goto M.
    AAPS PharmSciTech; 2015 Dec; 16(6):1418-24. PubMed ID: 25986596
    [Abstract] [Full Text] [Related]

  • 2. Transcutaneous immunotherapy of pollinosis using solid-in-oil nanodispersions loaded with T cell epitope peptides.
    Kong Q, Kitaoka M, Wakabayashi R, Kamiya N, Goto M.
    Int J Pharm; 2017 Aug 30; 529(1-2):401-409. PubMed ID: 28705615
    [Abstract] [Full Text] [Related]

  • 3. Approaches to immunotherapies for Japanese cedar pollinosis.
    Sakaguchi M, Hirahara K, Fujimura T, Toda M.
    Auris Nasus Larynx; 2011 Aug 30; 38(4):431-8. PubMed ID: 21227607
    [Abstract] [Full Text] [Related]

  • 4. Oral immunotherapy with transgenic rice seed containing destructed Japanese cedar pollen allergens, Cry j 1 and Cry j 2, against Japanese cedar pollinosis.
    Wakasa Y, Takagi H, Hirose S, Yang L, Saeki M, Nishimura T, Kaminuma O, Hiroi T, Takaiwa F.
    Plant Biotechnol J; 2013 Jan 30; 11(1):66-76. PubMed ID: 23066780
    [Abstract] [Full Text] [Related]

  • 5. Transcutaneous pollinosis immunotherapy using a solid-in-oil nanodispersion system carrying T cell epitope peptide and R848.
    Kitaoka M, Naritomi A, Kawabe Y, Kamihira M, Kamiya N, Goto M.
    Bioeng Transl Med; 2017 Mar 30; 2(1):102-108. PubMed ID: 29313026
    [Abstract] [Full Text] [Related]

  • 6. T cell epitopes in Japanese cedar (Cryptomeria japonica) pollen allergens: choice of major T cell epitopes in Cry j 1 and Cry j 2 toward design of the peptide-based immunotherapeutics for the management of Japanese cedar pollinosis.
    Sone T, Morikubo K, Miyahara M, Komiyama N, Shimizu K, Tsunoo H, Kino K.
    J Immunol; 1998 Jul 01; 161(1):448-57. PubMed ID: 9647255
    [Abstract] [Full Text] [Related]

  • 7. Oral immunotherapy for pollen allergy using T-cell epitope-containing egg white derived from genetically manipulated chickens.
    Kawabe Y, Hayashida Y, Numata K, Harada S, Hayashida Y, Ito A, Kamihira M.
    PLoS One; 2012 Jul 01; 7(10):e48512. PubMed ID: 23144766
    [Abstract] [Full Text] [Related]

  • 8. Cross-reactivity between major IgE core epitopes on Cry j 2 allergen of Japanese cedar pollen and relevant sequences on Cha o 2 allergen of Japanese cypress pollen.
    Miyaji K, Okamoto N, Saito A, Yasueda H, Takase Y, Shimakura H, Saito S, Sakaguchi M.
    Allergol Int; 2016 Jul 01; 65(3):286-92. PubMed ID: 26916996
    [Abstract] [Full Text] [Related]

  • 9. Clinical trials of Cry j 1 and Cry j 2 T-cell epitope peptide-expressing rice in patients with Japanese cedar pollinosis.
    Hashimotoi Y, Kawata M, Mino N, Ogino S, Takeda N, Kawashima K, Takagi H, Wakasa Y, Takano M, Tanaka M, Tohda Y, Tanaka T.
    Asian Pac J Allergy Immunol; 2022 Dec 01; 40(4):386-392. PubMed ID: 31586486
    [Abstract] [Full Text] [Related]

  • 10. Recognition of T cell epitopes unique to Cha o 2, the major allergen in Japanese cypress pollen, in allergic patients cross-reactive to Japanese cedar and Japanese cypress pollen.
    Sone T, Dairiki K, Morikubo K, Shimizu K, Tsunoo H, Mori T, Kino K.
    Allergol Int; 2009 Jun 01; 58(2):237-45. PubMed ID: 19307778
    [Abstract] [Full Text] [Related]

  • 11. Effect of Cry-consensus peptide, a novel recombinant peptide for immunotherapy of Japanese cedar pollinosis, on an experimental allergic rhinitis model in B10.S mice.
    Tsunematsu M, Yamaji T, Kozutsumi D, Murakami R, Kimura S, Kino K.
    Allergol Int; 2007 Dec 01; 56(4):465-72. PubMed ID: 17965586
    [Abstract] [Full Text] [Related]

  • 12. Analysis of sequential immunoglobulin E-binding epitope of Japanese cedar pollen allergen (Cry j 2) in humans, monkeys and mice.
    Tamura Y, Kawaguchi J, Serizawa N, Hirahara K, Shiraishi A, Nigi H, Taniguchi Y, Toda M, Inouye S, Takemori T, Sakaguchi M.
    Clin Exp Allergy; 2003 Feb 01; 33(2):211-7. PubMed ID: 12580914
    [Abstract] [Full Text] [Related]

  • 13. The incidence of Japanese cedar pollinosis and sensitization to the pollen allergens among Japanese monkeys in a troop.
    Sakaguchi M, Kobayashi C, Inouye S, Saito S, Hirahara K, Shiraishi A, Konaka A, Yamada T, Nigi H.
    Immunology; 1999 Jul 01; 97(3):522-5. PubMed ID: 10447776
    [Abstract] [Full Text] [Related]

  • 14. The incidence of japanese cedar pollinosis and sensitization to the pollen allergens among Japanese monkeys in a troop.
    Sakaguchi M, Kobayashi C, Inouye S, Saito S, Hirahara K, Shiraishi A, Konaka A, Yamada T, Nigi H.
    Immunology; 1999 Jun 01; 97(2):348-51. PubMed ID: 10447752
    [Abstract] [Full Text] [Related]

  • 15. Identification of human T cell epitopes in Japanese cypress pollen allergen, Cha o 1, elucidates the intrinsic mechanism of cross-allergenicity between Cha o 1 and Cry j 1, the major allergen of Japanese cedar pollen, at the T cell level.
    Sone T, Dairiki K, Morikubo K, Shimizu K, Tsunoo H, Mori T, Kino K.
    Clin Exp Allergy; 2005 May 01; 35(5):664-71. PubMed ID: 15898991
    [Abstract] [Full Text] [Related]

  • 16. Analysis of helper T cell responses to Cry j 1-derived peptides in patients with nasal allergy: candidate for peptide-based immunotherapy of Japanese cedar pollinosis.
    Masuyama K, Chikamatsu K, Ikagawa S, Matsuoka T, Takahashi G, Yamamoto T, Endo S.
    Allergol Int; 2009 Mar 01; 58(1):63-70. PubMed ID: 19050376
    [Abstract] [Full Text] [Related]

  • 17. Preclinical evaluation of an immunotherapeutic peptide comprising 7 T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen allergens.
    Hirahara K, Tatsuta T, Takatori T, Ohtsuki M, Kirinaka H, Kawaguchi J, Serizawa N, Taniguchi Y, Saito S, Sakaguchi M, Inouye S, Shiraishi A.
    J Allergy Clin Immunol; 2001 Jul 01; 108(1):94-100. PubMed ID: 11447388
    [Abstract] [Full Text] [Related]

  • 18. Identification of peptides containing T-cell epitopes of Japanese cedar (Cryptomeria japonica) pollen allergen (Cry j 1) in dogs.
    Masuda K, Sakaguchi M, Saito S, Yasueda H, Iwabuchi S, Tsukui T, Hayashi N, Nakao Y, Kurata K, Maeda S, Ohno K, Tsujimoto H.
    Vet Immunol Immunopathol; 2004 Nov 01; 102(1-2):45-52. PubMed ID: 15451614
    [Abstract] [Full Text] [Related]

  • 19. Recombinant Fusion Allergens, Cry j 1 and Cry j 2 from Japanese Cedar Pollen, Conjugated with Polyethylene Glycol Potentiate the Attenuation of Cry j 1-Specific IgE Production in Cry j 1-Sensitized Mice and Japanese Cedar Pollen Allergen-Sensitized Monkeys.
    Fujimura T, Fujinami K, Ishikawa R, Tateno M, Tahara Y, Okumura Y, Ohta H, Miyazaki H, Taniguchi M.
    Int Arch Allergy Immunol; 2015 Nov 01; 168(1):32-43. PubMed ID: 26524293
    [Abstract] [Full Text] [Related]

  • 20. Biological assay using T cell response for Cry-consensus peptide designed for the peptide-based immunotherapy of Japanese cedar pollinosis.
    Kozutsumi D, Tsunematsu M, Yamaji T, Kino K.
    J Pharmacol Toxicol Methods; 2007 Nov 01; 55(3):297-302. PubMed ID: 16996752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.